copper peptide ghk cu hair growth clinical trial humans 10% GHK-CU, 5% AHK-CU peptides Treatment Serum GHK-Cu Peptides Before and After:

Multiple clinical trials and controlled studies have demonstrated: Statistically significant improvements in skin firmness and elasticity with consistent use Reduction in fine lines and wrinkle depth over 3-6 months of application Improved skin density, moisture retention, and surface texture Reduction in photodamage and hyperpigmentation Tightening of loose skin documented in both topical and injectable applications Citation: Leyden JJ et al

FOXO4-DRI treatment significantly reduced the percentage of tubular cells lacking LMNB1, decreased IL-6 expression, and improved overall renal architecture

2-4 "We recognize the complex interplay between cardiovascular and metabolic diseases, including type 2 diabetes and obesity, which require a personalized treatment approach," said Martin Holst Lange, Executive Vice President for Development at Novo Nordisk

Finally, therapy as the recovering effect it has on occluded vessels (Duzel et al., 2017

Hence, the safety associated with copper delivery through the skin needs to be established